Global Endovascular Aneurysm Repair Market - 2022-2029

Market Overview

Endovascular Aneurysm Repair market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.6% during the forecast period (2022-2029).

An aortic aneurysm is a condition in which the aorta becomes enlarged. Abdominal pain, low blood pressure, loss of consciousness, and even death can result from these diseases. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical procedure that can treat abdominal and thoracic aortic aneurysms. It is a less invasive and less time-consuming alternative to open surgery for abdominal aortic aneurysms (AAA).

Market Dynamics

Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.

Polymer-based technology has been proposed for treating AAA with an endovascular approach. Two different polymer-based platforms have been developed for clinical purposes. The polymer device to create a circumferential sealing of the aneurysm has proven safe and effective. Moreover, adapting the O-ring to the aortic wall, this polymer-based platform offers a customized sealing of the aneurysm, which remains stable over the years without influencing neck dilatation. The low profile of such a platform based on polymer channels rather than traditional metallic stent frames to support the fabric may expand patient applicability for a minimally invasive EVAR treatment. The impact of this kind of technology is already significant. Therefore, the possibility of using polymer characteristics to create a customized sealing of the aneurysm has been a great revolution in EVAR procedures. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

The stent moment leads to the risk of an aneurysm and congestive heart failure, insufficient reimbursement policies, and the inflated cost of EVAR procedures compared to open surgeries. These are some of the factors that the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic included a substantial reduction in the number of cardiovascular procedures performed, including repair of Abdominal Aortic Aneurysms (AAA). For instance, AAA screening (including surveillance) in most areas of the UK was paused during the lockdown due to concerns about COVID-19 transmission and while strategies are considered regarding mitigating risk from delayed surgical intervention (as a result of reduced capacity within the NHS). Moreover, ruptured AAA carries a high mortality and screening for AAA. Circa 300,000 men are offered screening annually, of whom around 1% are found to have an AAA, while approximately 15,000 men are yet to tests. Thus, the market will undergo impetus during the forecast period.

Industry Analysis

The endovascular aneurysm repair market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The adjunctive stent graft segment is expected to hold the largest market share in the endovascular aneurysm repair market.

The adjunctive stent-graft segment accounted for the largest market share in 2021. Adjunctive stenting significantly reduces the risk of postoperative stent-graft limb occlusion without obvious compromise to the aneurysm repair. Endovascular grafting is a minimally invasive method to treat an aortic aneurysm. Through minor incisions in the groin, a stent graft (a fabric tube supported by metal wire stents that support the weak area in the aorta) is placed into the aneurysm. Endovascular aneurysm treatment does not require a major incision and has a significantly quicker recovery than traditional open surgery. Therefore, it increased the demand for adjunctive stent graft, due to which the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global endovascular aneurysm repair market.

North America accounted for the highest revenue share in 2021. The increasing prevalence of aneurysms and the rising geriatric population are more prone to this condition, due to which the market is expected to boost in the forecast period. For instance, Aortic aneurysms have an incidence of 5-10 cases per 100,000 in the United States and are more common in men over 60. Though aortic aneurysms do not directly cause death, complications arising from an aneurysm - such as dissection or rupture - cause approximately 15,000 deaths annually. AA primarily affects elderly males in the sixth and seventh decades of life with tobacco use, hypertension and atherosclerosis risk factors. For AAA, individuals with first-degree family members with the disease are at two-fold risk of developing AAA compared to patients with no family history. Moreover, according to the Population Reference Bureau report, the number of Americans aged 65 and up is expected to double by 2060, from 46 million to nearly 98 million. Therefore, it increases the demand for AAA treatments such as EVAR, due to which the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the endovascular aneurysm repair market are Cardinal Health, Lombard Medical Limited, Endologix Inc., Terumo Corporation, MicroPort Scientific Corporation, JOTEC GmbH, W. L. Gore & Associates, Inc., Cook Group Incorporated and Medtronic plc.

Medtronic plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Heli-FX EndoAnchor system: The Heli-FX EndoAnchor system is intended to provide fixation and sealing between endovascular aortic grafts and the native artery.

The global endovascular aneurysm repair market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.